Colombia vs Oman: Cause of death, by non-communicable diseases, ages 15-59, female
Colombia
50.3%
in 2021
Oman
51.1%
in 2021
Colombia rank
133rd
Oman rank
130th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Colombia
- Oman
How they compare
Oman currently reports 51.1% against 50.3% in Colombia, a difference of 0.8%.
Across all 6 years both countries report, Oman has been ahead every year.
Colombia ranks 133rd and Oman ranks 130th of 185 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Colombia | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 64.9% | 76.9% | 12.0% | Oman |
| 2010s | 72.3% | 78.8% | 6.4% | Oman |
| 2020s | 57.3% | 58.5% | 1.2% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Colombia or Oman?
- Oman, at 51.1% against 50.3% in Colombia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Colombia and Oman?
- 0.8%, with Oman ahead.
- How many years of comparable data are there for Colombia and Oman?
- 6 years are reported by both, from 2000 to 2021.
- How do Colombia and Oman rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Colombia ranks 133rd and Oman ranks 130th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.